Age-Standardized Mortality Rate Attributed to Noncommunicable Diseases in Syria
Syria: Age-Standardized Mortality Rate Attributed to Noncommunicable Diseases was 633.51 in 2019. ▼ Falling
Age-Standardized Mortality Rate Attributed to Noncommunicable Diseases in Syria, 2000–2019
Source: International Monetary Fund.
Analysis
The most recent figure for age-standardized mortality rate attributed to noncommunicable diseases in Syria is 633.51, measured in 2019.
The figure is up 0.2% on the previous year and up 0.6% over ten years.
Over the whole period, age-standardized mortality rate attributed to noncommunicable diseases in Syria peaked at 777.8 in 2000 and was at its lowest, 588.72, in 2015.
That places Syria 54th out of 181 countries with data for 2019, putting it in the middle of the range.
The long-run direction has been consistently falling across the 20 years of available data.
Age-Standardized Mortality Rate Attributed to Noncommunicable Diseases in Syria, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 777.8 | — |
| 2001 | 736.25 | -5.3% |
| 2002 | 724.39 | -1.6% |
| 2003 | 678.45 | -6.3% |
| 2004 | 665.43 | -1.9% |
| 2005 | 647.72 | -2.7% |
| 2006 | 636.78 | -1.7% |
| 2007 | 634.92 | -0.3% |
| 2008 | 640.05 | +0.8% |
| 2009 | 630.03 | -1.6% |
| 2010 | 634.71 | +0.7% |
| 2011 | 630.62 | -0.6% |
| 2012 | 629.28 | -0.2% |
| 2013 | 643.16 | +2.2% |
| 2014 | 601.49 | -6.5% |
| 2015 | 588.72 | -2.1% |
| 2016 | 615.16 | +4.5% |
| 2017 | 635.5 | +3.3% |
| 2018 | 632.56 | -0.5% |
| 2019 | 633.51 | +0.2% |
Syria compared with similar countries
- Syria's 633.51 is below the median for low income countries, which is 634.91, 100% of the median. (24 countries reporting)
- Syria's 633.51 is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 584.42, 1.1× the median. (22 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 677.18 | 630.03 | 777.8 | 10 |
| 2010s | 624.47 | 588.72 | 643.16 | 10 |
Countries ranked near Syria
More gender data for Syria
- Child population (UN estimates and projections) 8,107 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 3.23 % change on previous year (2030)
- Population 21,289 (2030)
- Working-age population (UN estimates and projections) 21,289 (2030)
- Population (UN estimates and projections), annual growth rate 2.03 % change on previous year (2030)
- Age population, age 00, female, interpolated 288,104 (2025)
- Age population, age 00, male, interpolated 302,347 (2025)
- Age population, age 01, female, interpolated 273,777 (2025)
- Age population, age 01, male, interpolated 287,191 (2025)
- Age population, age 02, female, interpolated 255,304 (2025)
Frequently asked questions
- What is age-standardized mortality rate attributed to noncommunicable diseases in Syria?
- Age-standardized mortality rate attributed to noncommunicable diseases in Syria was 633.51 in 2019, according to International Monetary Fund.
- What is the highest age-standardized mortality rate attributed to noncommunicable diseases recorded in Syria?
- The highest recorded value was 777.8 in 2000.
- What is the lowest age-standardized mortality rate attributed to noncommunicable diseases recorded in Syria?
- The lowest recorded value was 588.72 in 2015.
- How does Syria rank for age-standardized mortality rate attributed to noncommunicable diseases?
- Syria ranks 54th out of 181 countries with data for 2019.
- Is age-standardized mortality rate attributed to noncommunicable diseases rising or falling in Syria?
- Over the last ten years it is up 0.6%. The long-run trend across the full record is falling.
- Where does this Syria data come from?
- The figures come from International Monetary Fund, published as part of Age-Standardized Mortality Rate Attributed to Noncommunicable Diseases. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under IMF Terms and Conditions (attribution required).
About this data
Gender-disaggregated data on health outcomes.